Esther A. Peguero-Peterson

Pr 00931
San Juan, Puerto Rico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity.

Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity.

Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025

Pharmacological inhibition of NMDA receptors reduces migration and viability in triple-negative inflammatory breast cancer cell lines.

Pharmacological inhibition of NMDA receptors reduces migration and viability in triple-negative inflammatory breast cancer cell lines.

Journal: Discover oncology
Published: May 30, 2025

Synthesis and Biological Evaluation of Herceptin-Conjugated Liposomes Loaded with Lipocalin-2 siRNA for the Treatment of Inflammatory Breast Cancer.

Synthesis and Biological Evaluation of Herceptin-Conjugated Liposomes Loaded with Lipocalin-2 siRNA for the Treatment of Inflammatory Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 17, 2025

Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity.

Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity.

Journal: G3 (Bethesda, Md.)
Published: May 15, 2025

Protocol for evaluating the impact of non-coding variants on transcription factor binding and gene expression.

Protocol for evaluating the impact of non-coding variants on transcription factor binding and gene expression.

Journal: STAR protocols
Published: March 27, 2025

Cardiovascular disease-associated non-coding variants disrupt GATA4-DNA binding and regulatory functions.

Cardiovascular disease-associated non-coding variants disrupt GATA4-DNA binding and regulatory functions.

Journal: HGG advances
Published: October 15, 2024

Design of Extended Bisphosphonate-Based Coordination Polymers as Bone-Targeted Drug Delivery Systems for Breast Cancer-Induced Osteolytic Metastasis and Other Bone Therapies.

Design of Extended Bisphosphonate-Based Coordination Polymers as Bone-Targeted Drug Delivery Systems for Breast Cancer-Induced Osteolytic Metastasis and Other Bone Therapies.

Journal: Inorganic chemistry
Published: June 06, 2023

Beyond Antiresorptive Activity: Risedronate-Based Coordination Complexes To Potentially Treat Osteolytic Metastases.

Beyond Antiresorptive Activity: Risedronate-Based Coordination Complexes To Potentially Treat Osteolytic Metastases.

Journal: ACS applied bio materials
Published: February 14, 2023

Functionalization of Titanium Dioxide by In Situ Surface Crystallization of Bisphosphonate-Based Coordination Complexes.

Functionalization of Titanium Dioxide by In Situ Surface Crystallization of Bisphosphonate-Based Coordination Complexes.

Journal: Inorganic chemistry
Published: December 22, 2022

High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases.

High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases.

Journal: Materials advances
Published: November 30, 2021
Showing 1-10 of 10

Last Updated: 09/26/2026